ARTICLE | Company News
BioInvent, NVO antibody deal
March 19, 2001 8:00 AM UTC
Novo Nordisk and BioInvent agreed to develop antibodies to be used in drug discovery. BioInvent will supply human antibody fragments for use as research reagents from its n-CoDeR phage display library...